135 related articles for article (PubMed ID: 24790369)
1. MAMLD1 (CXorf6) is a New Gene for Hypospadias.
Ogata T; Fukami M; Wada Y
Clin Pediatr Endocrinol; 2008; 17(4):87-93. PubMed ID: 24790369
[TBL] [Abstract][Full Text] [Related]
2. MAMLD1 (CXorf6): a new gene for hypospadias.
Ogata T; Wada Y; Fukami M
Sex Dev; 2008; 2(4-5):244-50. PubMed ID: 18987498
[TBL] [Abstract][Full Text] [Related]
3. MAMLD1 (CXorf6): a new gene involved in hypospadias.
Ogata T; Laporte J; Fukami M
Horm Res; 2009; 71(5):245-52. PubMed ID: 19339788
[TBL] [Abstract][Full Text] [Related]
4. Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence.
Fukami M; Wada Y; Okada M; Kato F; Katsumata N; Baba T; Morohashi K; Laporte J; Kitagawa M; Ogata T
J Biol Chem; 2008 Feb; 283(9):5525-32. PubMed ID: 18162467
[TBL] [Abstract][Full Text] [Related]
5. MAMLD1 and 46,XY disorders of sex development.
Ogata T; Sano S; Nagata E; Kato F; Fukami M
Semin Reprod Med; 2012 Oct; 30(5):410-6. PubMed ID: 23044878
[TBL] [Abstract][Full Text] [Related]
6. Mamld1 deficiency significantly reduces mRNA expression levels of multiple genes expressed in mouse fetal Leydig cells but permits normal genital and reproductive development.
Miyado M; Nakamura M; Miyado K; Morohashi K; Sano S; Nagata E; Fukami M; Ogata T
Endocrinology; 2012 Dec; 153(12):6033-40. PubMed ID: 23087174
[TBL] [Abstract][Full Text] [Related]
7. Mamld1 knockdown reduces testosterone production and Cyp17a1 expression in mouse Leydig tumor cells.
Nakamura M; Fukami M; Sugawa F; Miyado M; Nonomura K; Ogata T
PLoS One; 2011 Apr; 6(4):e19123. PubMed ID: 21559465
[TBL] [Abstract][Full Text] [Related]
8. CXorf6 is a causative gene for hypospadias.
Fukami M; Wada Y; Miyabayashi K; Nishino I; Hasegawa T; Nordenskjöld A; Camerino G; Kretz C; Buj-Bello A; Laporte J; Yamada G; Morohashi K; Ogata T
Nat Genet; 2006 Dec; 38(12):1369-71. PubMed ID: 17086185
[TBL] [Abstract][Full Text] [Related]
9. MAMLD1 and Differences/Disorders of Sex Development: An Update.
Miyado M; Fukami M; Ogata T
Sex Dev; 2022; 16(2-3):126-137. PubMed ID: 34695834
[TBL] [Abstract][Full Text] [Related]
10. A New
Yeste D; Aguilar-Riera C; Canestrino G; Fernández-Alvarez P; Clemente M; Camats-Tarruella N
Front Endocrinol (Lausanne); 2022; 13():884107. PubMed ID: 35837313
[No Abstract] [Full Text] [Related]
11. Mutations of CXorf6 are associated with a range of severities of hypospadias.
Kalfa N; Liu B; Klein O; Audran F; Wang MH; Mei C; Sultan C; Baskin LS
Eur J Endocrinol; 2008 Oct; 159(4):453-8. PubMed ID: 18635673
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostics of disorders of sexual development: an Indian survey and systems biology perspective.
Nagaraja MR; Gubbala SP; Delphine Silvia CRW; Amanchy R
Syst Biol Reprod Med; 2019 Apr; 65(2):105-120. PubMed ID: 30550360
[TBL] [Abstract][Full Text] [Related]
13. Association of MAMLD1 single-nucleotide polymorphisms with hypospadias in Chinese Han population.
Liu Y; Ye W; Wu M; Huang Y
Front Biosci (Landmark Ed); 2017 Mar; 22(7):1173-1176. PubMed ID: 28199199
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of MAMLD1 gene in hypospadias.
Kalfa N; Cassorla F; Audran F; Oulad Abdennabi I; Philibert P; Béroud C; Guys JM; Reynaud R; Alessandrini P; Wagner K; Bréaud J; Valla JS; Morisson Lacombe G; Daures JP; Baskin L; Fukami M; Ogata T; Sultan C
J Pediatr Urol; 2011 Dec; 7(6):585-91. PubMed ID: 22030455
[TBL] [Abstract][Full Text] [Related]
15. Mutational study of the MAMLD1-gene in hypospadias.
Chen Y; Thai HT; Lundin J; Lagerstedt-Robinson K; Zhao S; Markljung E; Nordenskjöld A
Eur J Med Genet; 2010; 53(3):122-6. PubMed ID: 20347055
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical course in three patients with MAMLD1 mutations.
Fujisawa Y; Fukami M; Hasegawa T; Uematsu A; Muroya K; Ogata T
Endocr J; 2016 Sep; 63(9):835-839. PubMed ID: 27383042
[TBL] [Abstract][Full Text] [Related]
17. Novel Splice Site Mutation in MAMLD1 in a Patient with Hypospadias.
Igarashi M; Wada Y; Kojima Y; Miyado M; Nakamura M; Muroya K; Mizuno K; Hayashi Y; Nonomura K; Kohri K; Ogata T; Fukami M
Sex Dev; 2015; 9(3):130-5. PubMed ID: 25833151
[TBL] [Abstract][Full Text] [Related]
18. Screening of MAMLD1 mutations in 70 children with 46,XY DSD: identification and functional analysis of two new mutations.
Kalfa N; Fukami M; Philibert P; Audran F; Pienkowski C; Weill J; Pinto G; Manouvrier S; Polak M; Ogata T; Sultan C
PLoS One; 2012; 7(3):e32505. PubMed ID: 22479329
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of MAMLD1 Expression Suppresses the Growth and Migratory Properties of Gonadotroph Pituitary Adenomas.
Qi J; Ni W
Pathol Oncol Res; 2020 Apr; 26(2):937-946. PubMed ID: 30911995
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular spectrum of 46,XY disorders of sex development that harbour MAMLD1 variations: case series and review of literature.
Li L; Su C; Fan L; Gao F; Liang X; Gong C
Orphanet J Rare Dis; 2020 Jul; 15(1):188. PubMed ID: 32690052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]